The Effectiveness of Group Metacognitive Therapy for
Generalised Anxiety Disorder: A Pilot Study Colin van der Heiden Kim Melchior Ella de Stigter J Contemp Psychother (2013) 43:151157 DOI 10.1007/s10879-013-9235-y Published online: 2 April 2013 Springer Science+Business Media New York 2013 Abstract Generalised anxiety disorder (GAD) responds well to individually delivered metacognitive therapy (MCT). The current study investigated the effectiveness of MCT administered to groups of patients with GAD in a general outpatient treatment centre. Thirty-three consecu-tively referred adult patients with GAD were assessed before treatment (pretreatment), after the last treatment session (posttreatment), and six months after treatment had ended (follow-up). Analyses of treatment effects were conducted for all patients entering the study (i.e., intent-to- treat analysis, using the last-observation-carried-forward procedure), and repeated for the patients who completed treatment (completers analysis), using paired samples t-tests. Further, effect sizes (ESs) and indices of clinical significance were calculated, and compared with those reported in studies into the efficacy and effectiveness of individually delivered MCT for GAD. Among both the intent-to-treat and the completers sample, large pre- to posttreatment reductions in symptoms of worry, trait-anx-iety, and general psychopathology. The magnitude of change and the degree of clinical significance were smaller than those reported in studies into the effectiveness of individually delivered MCT for GAD, whereas the attrition rate (27 %) was higher. It is tentatively concluded that MCT for GAD can be effectively delivered in a group format in a heterogenous clinical practice setting. Further evaluation is clearly indicated.
Introduction Generalized anxiety disorder remains a challenging con-dition to treat. Although there is little debate that cognitive-behavioral therapy (CBT) is an efficacious therapy for GAD (e.g., Hunot et al. 2007), reviews of the clinical significance have indicated that only about 50 % of treatment completers achieve high end-state functioning (Hunot et al. 2007) or recovery (Fisher 2006) following treatment. These data show that there is room for improvement and a need for augmentation of current CBT strategies. In an attempt to augment the efficacy of CBT for GAD several new treatments have been developed, based on models of the mechanisms and factors underlying pathological worry, the hallmark of this disorder (see Hoyer et al. 2011). One prominent example is a new form of cognitive therapy, which is based on the metacognitive model for GAD (Wells 1995). Within this model worry is regarded as an attempt to generate ways of coping for potentially threat-ening events, based on positive beliefs about the usefulness of worry (e.g., Worrying helps me cope). The resultant worrying increases distress before eventually reducing distress as the (internal) goal of worrying is accomplished. As such, the process of worry in itself is not considered to be unique for GAD nor sufficient to cause this anxiety disorder. Instead, GAD develops when negative beliefs about the uncontrollability and dangerousness of worry (e.g., If I cannot stop my worrying, I will go crazy) form. Such negative metacognitions begin to develop when worrying becomes inflexible and persistent. Once acti-vated, these beliefs about worrying result in meta-worry, in which patients with GAD worry about the fact that they worry. Meta-worry increases anxiety and worrisome thoughts, which ultimately lead to the use of counterpro-ductive mental regulation (e.g., thought suppression) and avoidance strategies (e.g., reassurance seeking and keeping away from worrisome situations). Following from this model, metacognitive therapy (MCT) focuses on modifi-cation of erroneous negative metacognitive beliefs, positive beliefs about worrying as an effective means of dealing with threat, and unhelpful strategies to avoid worry and to control thoughts. So far, MCT has been evaluated in one uncontrolled trial (Wells and King 2006), and two randomized con-trolled trials (Wells et al. 2010; Van der Heiden et al. 2012), all of which achieved quite favorable results. That is, MCT produced significant and sustained improvements on all outcome variables, with large effect sizes (ESs) and high recovery rates. Further, MCT was found to be superior to applied relaxation (Wells et al. 2010) and to another specific form of CBT for GAD based on the intolerance-of-uncertainty model (IUT) (Van der Heiden et al. 2012) on measures of worry, trait-anxiety, and metacognitions. The treatments in those three studies were all individ-ually delivered, whereas group therapy might be an attractive alternative for several reasons, such as a more effective use of therapists time, peer modeling and peer support (Himle et al. 2003; Yalom and Leszcz 2005). To date, only two studies have been dedicated to determining the efficacy of group behavioral and cognitive therapies for GAD. In a first study, 109 patients with GAD were allo-cated to either cognitive, behavioral, cognitive-behavioral or placebo group therapy, or to a waiting list control con-dition (White et al. 1992). The four treatment conditions all showed significant change when compared to the waiting list control group, but only few differences emerged between the conditions. Moreover, recovery rates (on the STAI-T) were only poor, ranging from 17 to 30 % at posttreatment and 2033 % at six months follow-up (Fisher 2006). In a second, more recent study (Dugas et al. 2003), using intolerance of uncertainty (IU) as the target variable of a group CBT approach, 52 patients were randomly assigned to either group-IUT or a wait-list control group. Results showed that the treatment group had greater improvement on all dependent variables. Recovery rates were comparable to individual CBT-approaches, with both treatments achieving recovery rates of approximately 50 %. However, group-IUT showed a marked increase in recovery rates over the 1-year follow-up phase, from 48 to 64 %. As the large ESs and high recovery rates suggest that MCT is a highly effective treatment for GAD, and there is a paucity of research into the effectiveness of group ther-apy for GAD, the primary goal of this study is to examine the effectiveness of MCT when administered to groups of patients with GAD. To evaluate the potential of group MCT for GAD, treatment outcome data are compared with data collected in an earlier study conducted at our center that utilized individual MCT (Van der Heiden et al. 2012). Due to the sequential delivery of individual and group treatment, the results of the two studies cannot be com-bined. However, using ESs and recovery rates, the out-comes of group MCT will be compared to the individual outcomes of Van der Heiden et al. (2012) as the treatment manuals, procedures and lead therapists were the same. This methodology allows for an estimation of the effec-tiveness of group MCT, without needing to use experimental controls (e.g., control conditions, randomization procedures), which are impractical, or even impossible, in routine mental health care. Additionally, we will also compare the ESs and recovery rates of both other studies on the efficacy and effectiveness of MCT for GAD, and the ESs of the two earlier studies on group-CBT for GAD.
Patients Thirty-three patients were found to meet the study inclusion criteria. All potential patients were willing to participate in the study and none had to be excluded. The sample con-sisted of 12 men and 21 women. Their mean age was 31.33 years (SD = 8.96; range 1966 years). Twenty-four patients (73 %) had an additional diagnosis (panic disor-der = 8, major depressive disorder = 7, social phobia = 7, undifferentiated somatoform disorder = 1, obsessive compulsive disorder = 1). Twenty patients (61 %) were employed and the rest was unemployed or retired. Sixteen patients (48 %) were taking psychotropic medication (anti-depressants). Of the 33patients entering the study,9 (27 %) dropped out in the active treatment phase, and another 7 patients (21 %) were lost to follow-up. Further, of the 17 patients who com-pleted the study, 10 received additional treatment (for other problems) during the 6-month follow-up period. Therefore, the follow-up data were not included in the analyses, as they wouldbeinfluenced by the additional treatments. Analyses of treatment effects were conducted for all patients entering treatment (i.e., intent-to-treat analysis, using the last-obser-vation-carried-forward procedure), and repeated for the patients who completed treatment (completers analysis). Treatment MCT focuses on modifying metacognitive beliefs about worrying and increasing the flexible use of alternative strategies for dealing with triggers, instead of modifying the worry itself or teaching ways to control worrying (as is the case in most CBT approaches for GAD). Following case conceptualisation and socialisation to the metacogni-tive model, MCT proceeds with the direct modification of metacognitions by means of both verbal cognitive restructuring strategies (e.g., questioning the evidence supporting these beliefs, inducing cognitive dissonance by eliciting both positive and negative beliefs about worrying, employment of a mismatch strategy in which patients are asked to compare their worrisome predictions with the actual outcome of situations) and worry experiments. An example of the latter is a pushing-worry-to- the-limit experiment, in which negative beliefs about the specific dangers of worrying are tested by asking patients to worry more during distressing worry episodes. Positive meta-cognitions can be tested by worry modulation experiments, in which patients are asked to reduce worrying on one occasion and increase it on another occasion in order to determine whether greater worry indeed leads to more positive outcomes. The modification of beliefs about worry follows a particular sequence: first negative beliefs about the uncontrollability of worrying are targeted, then danger metacognitions are challenged, and finally positive beliefs concerning the usefulness of worry are addressed. In the final stage of MCT, alternative strategies for processing threatening triggers are explored (e.g., letting go of thoughts instead of trying to deal with them). Treatment comprised of 14 weekly 90-min sessions of MCT, which were administered to three groups of 1014 individuals. The mean number of sessions was 12.94 (SD = 0.66; range: 1214) for patients who completed the study, and 10.76 (SD = 3.71; range: 114) for the intent-to-treat sample. All sessions were highly structured and manualized to ensure treatment integrity. Treatment fol-lowed the manual by Van der Heiden et al. (2012), which was in turn based on the MCT treatment outline as developed by Wells (1997). The manual is described in detail elsewhere (Van der Heiden 2009). Discussion and Conclusion This is the first study into the effectiveness of MCT for GAD in a group format. In a general outpatient setting, group MCT produced large pre- to postreatment decreases in symptoms of worry and trait-anxiety among patients with GAD. The same was true for negative beliefs about worrying. As for the the datas clinical significance, results point to good outcomes. In conclusion, the results of this pilot study suggest that group MCT is effective in the treatment of patients with GAD, and support the continued evaluation of group MCT, which should be compared to both individually delivered MCT and other group treatments for GAD.
2. Interpersonal Emotion Regulation Model of Mood and Anxiety Disorders Cogn Ther Res DOI 10.1007/s10608-014-9620-1 - Springer Science+Business Media New York 2014 Published online: 23 May 2014Stefan G. Hofmann(&) Department of Psychology, Boston University, 648 Beacon Street, 6th Floor, Boston, MA 02215-2002, USA
Abstract Although social factors are of critical impor-tance in the development and maintenance of emotional disorders, the contemporary view of emotion regulation has been primarily limited to intrapersonal processes. Based on diverse perspectives pointing to the communicative function of emotions, the social processes in self-regulation, and the role of social support, this article presents an interpersonal model of emotion regulation of mood and anxiety disorders. This model provides a theoretical framework to understand and explain how mood and anxiety disorders are regulated and maintained through others. The literature, which provides support for the model, is reviewed and the clinical implications are discussed. Introduction Experiencing and regulating emotions are essential human qualities. As humans, we have the ability to empathize with another persons emotional state, because we know and sense what another person must feel like. Some of us are better able to empathize and experience another persons emotional state than others. This ability has been described with various terms, including empathy (Preston and de Waal 2002), theory of mind (Leslie 1987), emotional intelligence (Salovey and Mayer 1990), and alexithymia (Taylor et al. 1997). Emotional experiences are complex and differ on many levelsintensity, valence, duration, controllability, com-plexity, and action tendency (Barrett et al. 2007). To some extent, we do have control over our emotional experience, either by avoiding the situations, people, or triggers that elicit distress, or by changing our view of the situation. This ability has become known as emotion regulation (Gross 2002, 1998; Thompson 1994) and coping (Lazarus 2000; Lazarus and Folkman 1984). Coping researchers primarily examine responses to general stress, whereas emotion reg-ulation researchers examine strategies an individual pos-sesses to deal with specific positive and negative emotions. In addition to these intrapersonal processes, social pro-cesses also appear to be important aspects in the experience and expression of emotions. However, these processes have largely been ignored in contemporary theories of emotion regulation. This article will introduce an interpersonal model of emotion regulation for mood and anxiety disorders. This model offers a complementary framework to the popular intrapersonal emotion regulation model (Gross 2002). More specifically, the objective of this article is to: (1) briefly review the contemporary intrapersonal model of emotion regulation and discuss its limitations; (2) introduce an interpersonal model of emotion regulation; and (3) discuss the relevance of this interpersonal model of emotion regulation for the main-tenance and treatment of mood and anxiety disorders. Intrapersonal Emotion Regulation Models Recently, authors have explored the role of emotion reg-ulation and dysregulation in emotional disorders (Aldao et al. 2010), and especially mood and anxiety disorders (Amstadter 2008; Cisler et al. 2010; Berking et al. 2013, 2014; Hofmann et al. 2012; Mennin et al. 2005; Wirtz et al. 2014). Experimental studies have shown that participants with anxiety and mood disorders generally judge their negative emotions in response to a distressing film as less acceptable and tend to suppress their emotions to a greater extent than nonanxious participants (Campbell-Sills et al. 2006a). However, when instructed to accept their emotions, individuals with clinical diagnoses of anxiety or depression report less subjective distress and lower autonomic arousal than when asked to suppress their emotions in response to a distressing film (Campbell-Sills et al. 2006b). Similar effects have been observed in individuals who were asked to undergo a social stress task (Hofmann et al. 2009). In this study, participants were randomly assigned to reappraise, suppress, or accept their anticipatory anxiety prior to an impromptu speech. The instructions to suppress anxiety were associated with greater increase in physio-logical arousal than the instructions to reappraise and accept. Furthermore, the suppression group reported more subjective anxiety than the reappraisal group. However, the acceptance and suppression groups did not differ in their subjective anxiety response. Discussion The intrapersonal model of emotion regulation (e.g., Gross 2002; Gross and John 2003; Gross and Levenson 1997) has made an important contribution to the clinical field (Aldao et al. 2010). However, the intrapersonal model does not consider the communicative function of emotions and the self-regulatory processes that include social aspects. Social factors do not only act as input or moderating variables of the model. Rather, the model presented here suggests that emotions happen within a social context and are partly regulated through other people. Based on a recently pro-posed framework (Zaki and Williams 2013), I distinguished intrinsic versus extrinsic response-independent versus response-dependent interpersonal emotion regulation strat-egies for mood and anxiety disorders. Depending on the context, interpersonal strategies can be adaptive if they serve as a buffer of emotional stress and maladaptive if they contribute to the maintenance of the problem. An example of a maladaptive response-dependent and independent intrinsic emotion regulation strategy is the presence of a safety person for an individual with panic disorder and agoraphobia. Frequent or habitual use of interpersonal emotion regulation strategies can conceivably reduce the patients sense of control of his/her own emotion experience. Therefore, it is quite possible that interpersonal emotion regulation can become maladaptive if a patient becomes dependent on specific individuals or social groups in order to regulate ones own emotions. This model offers a transdi-agnostic perspective of emotional disorders by considering the broader social context of an individuals behavior and emotional experience. Despite these advantages, an interpersonal model of emotion regulation shows a number of weaknesses. First and foremost, this is a new model and there are no instruments available to measure interpersonal emotion regulation strategies. Therefore, the direct empirical evi-dence for the impact of these strategies on emotional dis-tress, including mood and anxiety disorders, is relatively weak. Any assessment instrument will need to consider the influence of the cultural context, because interpersonal emotion regulation strategies are directly related to social standards and expectations. Finally, it remains unknown how interpersonal and intrapersonal emotion regulation strategies interact and the relative importance of these strategies are unexplored. Although this review was primarily focused on mood and anxiety disorders, very similar issues probably also apply to other disorders. A fuller understanding of these issues can significantly advance our understanding of emotional disorders and can lead to new and improved treatment strategies.
Suneeta Monga, Diane Benoit - Assessing and Treating Anxiety Disorders in Young Children - The Taming Sneaky Fears Program-Springer International Publishing (2018)